All In Biotech

Drug Trial Radar · NCT00461526

Diarrhea Predominant Irritable Bowel Syndrome in Females

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRN-002 (Crofelemer) for the Symptomatic Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS) in Females

Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

240

Actual

Start

Oct 2006

Primary completion

Dec 2007

Study completion Dec 2007

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Apr 18, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Clinical Trial with TRN-002 in Women with Irritable Bowel Syndrome (IBS) The purpose of this study is to investigate the safety and effectiveness of a new investigational drug in women for the treatment of diarrhea-predominant irritable bowel syndrome. The investigational drug is a natural product taken from a plant that grows in South America. The study medication will be administered orally twice a day. Subjects will be not able to remain on certain standard IBS medications (anti-diarrheals) while participating in the study. The total duration of the study is 18 weeks. The study requires five study visits that include physical exams, ECG, blood draws, laboratory studies, and a colon procedure (such as a colonoscopy or flexible sigmoidoscopy if an appropriate procedure has not been performed in the last 5 years.) Participants will be asked to make entries into a touch-tone telephone diary on a daily basis. Participants must meet all of the following criteria: * Females at least 18 years of age * Diagnosis of diarrhea predominant Irritable Bowel Syndrome * Willingness to make daily calls on a touch-tone telephone * Willingness to have an endoscopic and/or radiologic bowel evaluation, if you have not received one in the past 5 years. * Willingness to take an approved method of birth control (if required) Participants CANNOT meet any of the following criteria: * Serious medical or surgical conditions * Colon Cancer, Crohns Disease or Ulcerative Colitis * Pregnant or breast feeding

Conditions

  • Irritable Bowel Syndrome

Interventions

  • crofelemerDrug

    125 mg crofelemer vs. placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the safety of TRN-002 when administered twice daily for 12 consecutive weeks.Time frame: March 2008
  2. To assess the efficacy of TRN-002 when administered twice daily for 12 consecutive weeks.Time frame: March 2008

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Associates, LLC

    Huntsville, Alabama

  • Radiant Research

    Chandler, Arizona

  • Genova Clinical Research

    Tucson, Arizona

  • Advanced Clinical Research Institute

    Anaheim, California

  • Community Clinical Trials

    Orange, California

  • Advanced Clinical Research Institute

    Orange, California

  • Medical Associates Research Group

    San Diego, California

  • Boulder Medical Center, PC

    Boulder, Colorado

  • Rocky Mountain Gastroenterology Associates

    Thornton, Colorado

  • Litchfield County Gastroenterology Associates, LLC

    Torrington, Connecticut

  • Washington Gastroenterology, PC

    Washington D.C., District of Columbia

  • Consultants of Clinical Research of South Florida

    Boynton Beach, Florida

  • University Clinical Research - DeLand

    DeLand, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • Mount Vernon Clinical Research

    Atlanta, Georgia

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Digestive and Liver Disease Consultants, PC

    Clive, Iowa

  • Trover Center for Clinical Studies

    Madisonville, Kentucky

  • Maryland Digestive Disease Research

    Laurel, Maryland

  • Gastroenterology Associates

    Jackson, Mississippi

  • Toby Village Office Park

    Pittsford, New York

  • LeBauer Research Associates, PA

    Greensboro, North Carolina

  • Vital re:Search

    Greensboro, North Carolina

  • Bethany Medical Center

    High Point, North Carolina

  • Hanover Medical Specialist, PA

    Wilmington, North Carolina

  • Piedmont Medical Research Associates

    Winston-Salem, North Carolina

  • Akron Gastroenterology Associates, Inc.

    Akron, Ohio

  • Research Solutions Corp.

    Cincinnati, Ohio

  • Gastrointestinal & Liver Disease Consultants

    Dayton, Ohio

  • Oklahoma Foundation for Digestive Research

    Oklahoma City, Oklahoma

  • Sooner Clinical Research

    Oklahoma City, Oklahoma

  • Grand View Medical Research

    Sellersville, Pennsylvania

  • Anderson Gastroenterology Associates, LLC

    Anderson, South Carolina

  • ClinSearch

    Chattanooga, Tennessee

  • Gastroenterology Center of the MidSouth, PC

    Germantown, Tennessee

  • Memphis Gastroenterology Group

    Germantown, Tennessee

  • The Jackson Clinic

    Jackson, Tennessee

  • Gastroenterology Associates

    Kingsport, Tennessee

  • Austin Gastroenterology, PA

    Austin, Texas

  • Trinity Clinic - Corsicana

    Corsicana, Texas

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.